Non-melanoma skin cancer diagnoses dwarf all other cancer diagnoses. Thankfully these cancer diagnoses rarely are fatal. That’s the good news. The bad news is that non-melanoma skin cancer, if not treated properly, can be disfiguring. And let’s be honest, even if non-melanoma skin cancer is rarely fatal, it is still a cancer diagnosis and rarely does not mean never. And, as the article linked and excerpted below states, “Skin cancer recurrences and severe side effects can take four or more years to appear.”
Non-Melanoma Skin Cancer at a Glance-
Therefore it is the non-melanoma skin cancer patient’s job to determine which therapy will result in the best outcome for him/her. “Standard treatments depend on the size, type, location and depth of the tumor and the patients age.” All therapies have risks and benefits, all therapies have side effects. The challenge is to do you homework to figure out what therapy has the best chance of satisfying your specific needs.
To learn more about other evidence-based therapies that can help prevent the development of non-melanoma skin cancer or relapse, please watch the short video below:
To learn more about non-melanoma skin cancer therapies, both conventional and non-conventional, scroll down the page, post a question or a comment and I will reply ASAP.
“The new procedure, called surface electronic brachytherapy, or eBx, is beginning to cause a stir in the world of non-melanoma skin cancers, the most common type of cancer. The American Academy of Dermatology’s official position is that surgery is the most effective treatment, and that more long-term data is needed before the safety and effectiveness of eBx can be determined…